FORMULATION AND OPTIMIZATION OF FLOATING SUSTAINED RELEASE TABLETS OF ATAZANAVIR SULFATE THROUGH BOX-BEHNKEN DESIGN
DOI:
https://doi.org/10.22159/ajpcr.2025v18i3.53791Keywords:
Floating time, Fourier-transform infrared spectroscopy, Scanning electron microscopy, Differential scanning calorimetry, Optimization,, Sustained releaseAbstract
Objective: Atazanavir (ATZ) sulfate is widely prescribed as an antiretroviral drug belonging to BCS class II with low solubility. This research aims to design, formulate, and optimization of floating sustained-release tablets of ATZ through Box-Behnken design (BBD).
Method: The formulation parameters were optimized using the BBD. Methocel K100M (A) was chosen as the primary release-retarding polymer, Sodium Bicarbonate (B) served as the gas-generating agent, Ethyl Cellulose (C) was utilized as an additional release-retarding polymer, and Cetyl Alcohol as a floating assistant. In this design, A, B, and C were designated as independent variables, while three response variables floating lag time (FLT) (Y1), swelling index (Y2), and percentage drug release (Y3) were selected as the dependent variables. The compatibility of the drug and excipients was evaluated through Fourier-transform infrared (FTIR) spectroscopy, differential scanning calorimetry (DSC), and morphology by scanning electron microscopy. Tablets were prepared through the direct compression method and subsequently evaluated for parameters including FLT, flotation time, swelling index, hardness, drug content, friability, in vitro drug release, and drug release kinetics.
Results: FTIR and DSC investigations revealed no interaction between the drug and the excipients, physical mixture of the drug and the excipients indicated the amorphous state of ATZ. All the evaluated tablets showed satisfactory results. The drug release from the validated optimized tablets was gradual and sustained over 12 h (99.76±0.75) following zero-order kinetics.
Conclusion: The optimized tablets with desirable formulation characters were determined through a statistical optimization model and the optimized formulation remarkably sustained the drug release for up to 12 h, indicating its improved therapeutic potential for the treatment of HIV.
Downloads
References
Li Q, Guan X, Cui M, Zhu Z, Chen K, Wen H, et al. Preparation and investigation of novel gastro-floating tablets with 3D extrusion-based printing. Int J Pharm. 2018;535(1-2):325-32. doi: 10.1016/j. ijpharm.2017.10.037, PMID: 29051121
Yashavanth G, Prakash G. Formulation and evaluation of sustained-release floating matrix tablets of valganciclovir hydrochloride. Int J Appl Pharm. 2024;16(2):195-20.
Lopes CM, Bettencourt CM, Rossi A, Buttini F, Barata P, Barata P. Overview on gastroretentive drug delivery systems for improving drug bioavailability. Int J Pharm. 2016;510(1):144-58. doi: 10.1016/j. ijpharm.2016.05.016, PMID: 27173823
Murali Krishna B, Patro CS, Ramarao CT, Uppala PK. Strategic approaches and evaluation of gastro retentive drug delivery system-A review. NeuroQuantology. 2022;20(7):757-69. doi: 10.14704/ nq.2022.20.7.NQ33097
Vankayala DS, Magharla DD, Anilkumar V, Chaitanya A. Response surface design for formulation and evaluation of floating oral in situ gelling system of famotidine for Ulcer. Bol Environ Pharmacol Life Sci. 2023;12:97-107.
Sundar VD, Divya P, Suneendra G, Dhanaraju MD. Design development and evaluation of gastroretentive floating microspheres of atazanavir sulphate. Int J Pharm Sci Res. 2018;9(11):4642-50.
Jonna S, Neeraj S. Formulation and evaluation of fixed-dose combination of bilayer tablets of atazanavir sulfate and ritonavir 300 mg/100 mg. Int J Appl Pharm. 2021;13(5):60-72.
Rajkumar J, Narayana Raju P, Radha GV, Kumar AS. Design and evaluation of atazanavir sulphate noneffervescent sustained release floating matrix tablets. Glob J Pharm Pharm Sci. 2019;7(4):555717.
Masareddy R, Sandure P, Patil A, Gaude Y, Patil A. In situ gastric floating gel of atazanavir sulphate for sustained release: Formulation, optimization and evaluation. Ther Deliv. 2023;14(10):619-33. doi: 10.4155/tde-2023-0037, PMID: 38054237
Dhanaraju MD, Sundar VD, Vadaga A, Ramya N. Design, formulation and optimization of liquisolid compact of atazanavir by using DoE approach. Eur Chem Bull. 2023;12(11):53-66.
Arpna I, Masheer KA. Box-Behnken design for optimization of formulation variables for controlled release gastroretentive tablet of verapamil hydrochloride. Int J Appl Pharm. 2023;15(1):256-63.
Srinivas L, Sagar S. Design, optimization, and evaluation of raft forming gastro retentive drug delivery system of lafutidine using box- Behnken design. Int J Appl Pharm. 2022;14(1):266-74.
Sundar VS, Dhanaraju MD, Vadaga A, Arigela C. Response surface design for formulation and evaluation of floating oral in situ gelling system of famotidine for ulcer. Bull Environ Pharmacol Life Sci. 2023;12(11):97-107.
Ramarao CT, Laxmi SB. Floating drug delivery of sustained release antidepressant mirtazapine tablets by box behnken design: Formulation and Optimization. Indian J Pharm Educ Res. 2024;58(1 Suppl):S113-25.
Challa TR, Reshma K. Experimental design statistically by design expert software: A model poorly soluble drug with dissolution enhancement and optimization. Int J Drug Deliv Technol. 2022;12(3):1367-75. doi: 10.25258/ijddt.12.3.72
Ramarao CT, Preethi G. Statistically optimization and formulation development of bromofenac sodium ophthalmic drug delivery. Suranaree J Sci Technol. 2022;29(6):070060.
Ramarao CT, Madhuri S. Statistically 2 level factorials by design Expert: In vitro design and formulation of Levitiracetam extended release tablets. Ind J Pharm Educ Res. 2022;56(4):994-1002. doi: 10.5530/ ijper.56.4.180
Kharwade RS, More SM, Mahajan UN. Formulation and evaluation of gastroretentive floating tablet using Hibiscus rosa-sinensis mucilage. Asian J Pharm Clin Res. 2017;10(3):444-8. doi: 10.22159/ajpcr.2017. v10i3.16494
Padma SV, Venkata Ramana K, Murthy P, Nagaraju V. Naik application of box-Behnken design for development and evaluation of gastric floating tablets of riboflavin. Eur Chem Bull. 2023; 12(2):304-10.
Ramarao CT, Vijaya Ratna J, Srinivasa RB. Design and characterization of alfuzosin Hcl gastroretentive floating matrix tablets employing HPMC K100 M. Indian Drugs. 2018;55(11):71-3. doi: 10.53879/ id.55.11.10741
Anusha K, Kalyani V, Venu K. Formulation and characterization of sustained release matrix tablets of verapamil hydrochloride using synthetic, semisynthetic, and natural polymer. World J Pharm Pharm Sci. 2019;8(5):1633-44.
Jain HK, Taware M. Formulation development and evaluation of gastro-retentive dosage form of atazanavir sulphate. Int J Pharm Pharm. 2021;10(1):60-70.
Kusuma A, Santosh Kumar R. Optimization of fast-dissolving tablets of carvedilol using 23 factorial design. Int J Appl Pharm. 2024;16:98-107. doi: 10.22159/ijap.2024v16i1.49535
Putta SK, Koteshwara K, Nayak UY, Pai SR, Pathuri R, Hn AR. Design of floating formulations and antiulcer activity of Desmostachya bipinnata. AAPS PharmSciTech. 2024;25(3):44. doi: 10.1208/s12249- 024-02745-6, PMID: 38383866
Yang HS, Kim DW. Fabrication of Gastro-floating famotidine tablets: Hydroxypropyl methylcellulose-based semisolid extrusion 3D printing. Pharmaceutics. 2023;15(2):316. doi: 10.3390/pharmaceutics15020316, PMID: 36839639
Dias G, Bobde SS, Desai P. Statistical design of experiment-based formulation development and optimization of floating matrix tablet of anti-emetic drug. Int J App Pharm. 2024;16(4):199-207.
Pragallapati P, Lakshmi Ponnuri RN, Murthy Kollapalli VR. Quality by design approach for development and optimization of chitosan based floating microspheres for topotecan HCl. Int J Appl Pharm. 2023;15(6):153-62.
Dias G, Bobde SS, Desai P. Statistical design of Experiment-based formulation development and optimization of floating matrix tablet of anti-emetic drug. Int J Appl Pharm. 2024;16:199-207. doi: 10.22159/ ijap.2024v16i4.50771
Rahamathulla M, Saisivam S, Alshetaili A, Hani U, Gangadharappa HV, Alshehri S, et al. Design and evaluation of losartan potassium effervescent floating matrix tablets: In vivo X-ray imaging and pharmacokinetic studies in Albino rabbits. Polymers (Basel) 2021;13(20):3476. doi: 10.3390/polym13203476
Rajkumar J, Raju PN, Radha GV, Kumar AS. Design and evaluation of atazanavir sulphate non-effervescent sustained release floating matrix tablets. Glob J Pharm Sci. 2019;7(4):105-16. doi: 10.19080/ GJPPS.2019.07.555717
Komati S, Dasi V, Jadi RK, Padala NR. Formulation development and characterization of Atazanavir Sulphate controlled release non-effervescent floating matrix tablets. J Drug Deliv Ther. 2019;9(4- A):601-607.
Krishnan I, Dhandapani TS, Seenivasan R, Sarvesh R, Sukeshan MP, Saravana Kumar CA, et al. Solubility enhancement of atazanavir by hydrotropic solubilization technique. Int J Appl Pharm. 2024;16(2):139-45.
Published
How to Cite
Issue
Section
Copyright (c) 2025 MURALI KRISHNA BALIJEPALLI
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
